================================================================================
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the Nine Months Ended September 30, 2001



                              --------------------



                         CAPITAL DEVELOPMENT GROUP, INC.
              -----------------------------------------------------
             (Exact name of registrant as specified in its charter)



             OREGON                                           93-1113777
- ------------------------------------------         -----------------------------
    (State or other jurisdiction                   (IRS Employer Identification
        of incorporation or                        No.)
           organization)


  4333 Orange Street, Suite 3600                       Riverside, CA 92501-3839
- ------------------------------------------         -----------------------------
  (Address of principal administrative               (City, State, Zip Code)
                offices)

                                 (909) 276-0873
                       -----------------------------------
                         (Registrants telephone number)



Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes     No  X
   -----  -----


State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

               Class                      Shares Outstanding, September 30, 2001
               -----                      --------------------------------------

     Common Stock, $.0001 par value                        15,000,000


PART I   FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

Financial Statements are included as part of this document at the end of the
document.


Item 2.  Management Discussion and Analysis or Plan of Operation

Disclosure regarding forward-looking statements.

This filing includes "forward-looking statements" as that term is defined in the
Private Securities Litigation Reform Act of 1995. Forward-looking statements are
based on management's beliefs and assumptions based on currently available
information. All statements other than statements of historical fact regarding
our financial position, business strategy and management's plans and objectives
for future operations are forward-looking statements. Although the Company
believes that management's expectations as reflected in forward-looking
statements are reasonable, we can give no assurance that those expectations will
prove to be correct. Forward-looking statements are subject to various risks and
uncertainties that may cause our actual results to differ materially and
adversely from our expectations as indicated in the forward-looking statements.
Many of these risks and uncertainties are disclosed in our recent filings with
the Securities and Exchange Commission, including those set forth below and
those disclosed in our quarterly report on Form 10-Q for the quarter ended June
30, 2000. You should be aware that these factors are not an exhaustive list, and
you should not assume these are the only factors that may cause our actual
results to differ from our expectations.


(a)      Plan of Operation

The company is currently evaluating companies to merge with and form a
profitable on-going concern.


(b)      Management's Discussion and Analysis of Financial Condition and Results
         of Operations

The Company has split IntraMed Corporation out of Capital Development Group,
Inc. The purpose of this was to transfer all of the assets and liabilities of
Capital Development Group into IntraMed. IntraMed is owned by the shareholders
of Capital Development Group in the proportional share that they own Capital
Development Group as of September 28, 2001. IntraMed gave Capital Development
Group some cash as part of the transaction to cover some of the Accounts
Payables that IntraMed did not assume.

PART II  OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS

No legal proceedings have occurred or are occurring in this quarter.

ITEM 2.  CHANGES OF SECURITIES

4,826,065 shares were issued during the period. These were issued for conversion
of debt to the company.


ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

No defaults have occurred this quarter.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted for a vote of the security holders this quarter.


ITEM 5.  OTHER INFORMATION

None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

None


SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Capital Development Group, Inc.


By: /s/ Michael P. Vahl, President
    ------------------------------
November 14, 2001

Appendix A:       Financial Statements

Balance Sheet as of                           09/30/2001         09/30/2000

Assets
   Current Assets
        Cash                                          18                288
        A/R, net                                       0                  0
        Other Current Assets                           0             85,500

   Total Current Assets                               18             85,788

   Fixed Assets, net                                   0             32,033

   Intangible Assets, net                              0             77,156

Total Assets                                          18            194,977


Liabilities & Stockholders Deficit

   Current Liabilities
        A/P & Accrued Liabilities                 42,795             27,580
        Due to Related Parties                         0            164,785
        Convertible Notes Payable                      0            210,000
        Notes Payable                                  0             15,000
        Other Liabilities                              0              1,553

   Total Current Liabilities                      42,795            418,919

   Stockholders Deficit

        Common Stock                               1,500                963
        Convertible Series A Preferred                 0                 16
        Additional Paid-in Capital             6,226,010          2,195,462
        Accumulated Deficit                   (6,270,286)        (2,420,383)

   Total Stockholders Deficit                    (42,777)          (223,942)

Total Liabilities & Stockholders Deficit              18            194,977

Income Statement for the 9 months ended               09/30/2001     09/30/2000

   Revenue                                              (13,886)       (17,304)

   Operating Expenses
        Consulting Fees                                  54,101         24,687
        Management Fees                                  83,750        113,692
        Other Expenses                                  182,499        122,729
        Depreciation & Amortization                     123,802              0

   Total Operating Expenses                             444,152        261,107

   Loss Before Provision for Income taxes              (458,039)      (278,412)

   Provision for Income Taxes                                 0              0

   Net Loss                                            (458,039)      (278,412)

Basic and Diluted loss per share                             (0)            (0)

Weighted Average # of Shares                         15,000,000      8,409,335



Cash Flows from Operating Activities
     for the  Months Ended                            09/30/2001     09/30/2000

Net Loss                                               (458,039)      (278,412)

Adj's to reconcile net loss to net cash

   Depreciation and Amortization                        123,802              0
   Interest Expense                                           0         (2,369)
   Changes in Operation Assets and Liabilities                0              0
        Accounts Receivable                                   0              0
        Accounts Payable and Accrued Liabilities        115,544         24,340
        Due to Related Parties                          179,883        127,615

Net Cash used by Operating Activities                   (38,809)      (128,825)

Net Cash used in Investing Activities                         0        129,113

Net Decrease in Cash                                    (38,809)           288

Cash at Beginning of Period                              38,827              0

Cash at end of Period                                        18            288

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION

Nature of Business

Capital Development Group, Inc. (the "Company") was incorporated in Oregon on
May 19, 1993. Prior to the acquisitions of IntraMed Corporation and HealthSource
Financial Advisors, LLC, (see Acquisitions of Subsidiaries discussed below) the
Company primarily engaged in the business of purchasing healthcare receivables
from hospitals and other healthcare institutions at a discount and administering
the collection process of such receivables. As of September 30, 2001, the
Company has redirected its efforts and has become primarily focused on the
operations of the newly acquired subsidiaries.

The Company is publicly traded on the Over the Counter Bulletin Board ("OTCBB")
under the symbol "CDVG". As discussed in Note 6, the Company is delinquent on
several required SEC filings.

Interim Financial Statements

The accompanying condensed financial statements include the accounts of the
Company. The information furnished has been prepared in accordance with
generally accepted accounting principles for interim financial reporting, the
instructions to Form 10-Q, and Rule 10-01 of Regulation S-X. Accordingly,
certain information and disclosures normally included in financial statements
prepared in accordance with generally accepted accounting principles have been
condensed or omitted. In the opinion of management, all adjustments considered
necessary for the fair presentation of the Company's financial position, results
of operations and cash flows have been included and are only of a normal
recurring nature. These financial statements have not undergone a SAS-71 review.
The results of operations for the quarter ended September, 2001 are not
necessarily indicative of the results of operations for the year ending December
31, 2001.

These financial statements should be read in conjunction with the Company's
audited December 31, 2000 consolidated financial statements included in Form
10-K.


2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Income Taxes

Using the liability method required by Statement of Financial Accounting
Standards ("SFAS") No. 109, "Accounting for Income Taxes," the estimated tax
effects of temporary differences between financial and income tax reporting are
recorded in the period in which the events occur. Such differences between the
financial and tax bases of assets and liabilities result in future tax
deductions or taxable income.

Based on management's best estimate of taxable income in the foreseeable future,
it is more likely than not that some portion of deferred income tax assets, due
mostly to net operating loss carryforwards, may not be realized.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Loss per Common Share

Loss per common share is based on the weighted average number of shares of
common stock and common stock equivalents outstanding during the year in
accordance with Statement of Financial Accounting Standards No. 128, "Earnings
per Share."


Recent Accounting Pronouncements

For the nine-month period ended September 30, 2001, the Company adopted
Statement of Financial Accounting Standards No. 133, "Accounting for Derivative
Instruments and Hedging Activities" ("SFAS 133"), as amended. Since the Company
does not presently engage in activities covered by SFAS 133, there was no
significant effect on the Company's September 30, 2001 condensed consolidated
financial statements.


3. NOTES PAYABLE

All notes payables issued by the Company along with their accrued interest have
been converted into common shares of the Company's stock


4. RELATED PARTY TRANSACTIONS

The Company's President/CEO, who is also approximately a 50% shareholder, has
converted approximately $211,000 of the accrued debt into the Company's common
stock. The balance of the debt has assumed by IntraMed Corporation.

The Company's Board of Directors voted to split off IntraMed Corporation on
September 28, 2001. IntraMed Corporation will be owned in a proportional number
of shares to the number of shares that are currently owned by the Company's
shareholders in the Company as of September 28, 2001. IntraMed Corporation
assumed all the Assets and Liabilities of Capital Development Group, Inc., as
well as any rights to all licenses and other potential settlements in exchange
for a small amount of cash to help pay the Company's existing Accounts Payables.


5. CONVERTIBLE SERIES A PREFERRED STOCK

All of the Company's convertible Series A preferred stock was converted into
250,000 shares of the Company's common stock in September 2001.


6. DELINQUENT SEC FILINGS

The Company's June 30, 2000 and September 30, 2000 Form 10-QSB's were not
reviewed by the Company's accountants in accordance with Statement on Auditing


Standards No. 71 ("SAS 71"), "Interim Financial Information". Federal securities
law requires SAS 71 reviews. Such filing delinquencies constitute securities
laws non-compliance and, among other actions enforceable by the SEC, could
result in de-listing of the Company's common stock from the OTCBB.

In addition, any owners of the Company's restricted securities who are otherwise
eligible to sell such securities under Rule 144 may be temporarily unable to do
so until such filing delinquencies are cured.


7. GOING CONCERN AND LIQUIDITY CONSIDERATIONS

The Company has not generated significant revenue or any profit from operations.
Such factors indicate that the Company may be unable to continue as a going
concern for a reasonable period of time. Management is in discussions with
potential investors to pursue additional capital infusions into the Company,
which management believes are necessary until such time that revenues achieve
profitability levels.

The condensed financial statements do not include any adjustments relating to
the recoverability of assets that might be necessary should the Company be
unable to continue as a going concern. The Company's continuation as a going
concern is dependent upon its ability to generate sufficient revenue and related
cash flow to meet its obligations on a timely basis and/or to obtain additional
financing or equity infusions as may be required.